<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        4-444-04
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2004
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        GLOCLAV 625MG TABLET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        AMOXICILLIN,CLAVULANIC ACID
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        500,125
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        48
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="GLOBAL PHARMA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            GLOBAL PHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 423]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            MANAYER NAJD TRADING MEDICAL NEEDS CO.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            GLOBAL PHARMA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01CR02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>It contains two different medicines called amoxicillin and clavulanic acid. Amoxicillin belongs to a group of medicines called &ldquo;penicillins&rdquo; that can sometimes be stopped from working (made inactive). The other active component (clavulanic acid) stops this from happening.</p><p><strong>Gloclav<sup> </sup>625mg </strong>is used in adults and children to treat the following infections:</p><p>&middot; middle ear and sinus infections&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>&middot; respiratory tract infections&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>&middot; urinary tract infections&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>&middot; bone and joint infections.</p><p>&middot; skin and soft tissue infections including dental infections&nbsp;&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot; if you are allergic to amoxicillin, clavulanic acid, penicillin or any of the other ingredients of Gloclav (listed in section 6).</p><p>&middot; if you have ever had a severe allergic (hypersensitive) reaction to any other antibiotic. This can include a skin rash or swelling of the face or throat.</p><p>&middot; if you have ever had liver problems or jaundice (yellowing of the skin) when taking an antibiotic.</p><p><strong>&rarr;Do not take </strong><strong>Gloclav if any of the above apply to you. </strong>If you are not sure, talk to your<strong> </strong>doctor or pharmacist before taking Gloclav.</p><p><strong>Warnings and precautions </strong></p><p>Talk to your doctor or pharmacist before taking this medicine if you:</p><p>&middot; have glandular fever&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>&middot; are being treated for liver or kidney problems</p><p>&middot; are not passing water regularly.</p><p>If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking Gloclav. In some cases, your doctor may investigate the type of bacteria that is causing your infection. Depending on the results, you may be given a different strength of Gloclav or a different medicine.</p><p><strong>Conditions you need to look out for</strong></p><p>Gloclav<strong> </strong>can make some existing conditions worse, or cause serious side effects. These include allergic reactions, convulsions (fits) and inflammation of the large intestine. You must look out for certain symptoms while you are taking Gloclav, to reduce the risk of any problems. See &lsquo;Conditions you need to look out for&rsquo; in Section 4.</p><p><strong>Blood and urine tests</strong></p><p>If you are having blood tests (such as red blood cell status tests or liver function tests) or urine tests (for glucose), let the doctor or nurse know that you are taking Gloclav. This is because Gloclav can affect the results of these types of tests.</p><p><strong>Using other medicines and Gloclav </strong></p><p>Please tell your doctor or pharmacist if you are using, have recently used or might use any other medicines. This includes medicines that can be bought without a prescription and herbal medicines.</p><p>&middot; If you are taking allopurinol (used for gout) with Gloclav, it may be more likely that you will have an allergic skin reaction.</p><p>&middot; If you are taking probenecid (used for gout), your doctor may decide to adjust your dose of Gloclav.</p><p>&middot; If medicines to help stop blood clots (such as warfarin) are taken with Gloclav then extra blood tests may be needed.</p><p>&middot; Gloclav can affect how methotrexate (a medicine used to treat cancer or rheumatic diseases) works.</p><p>&middot; Gloclav may affect how mycophenolate mofetil (a medicine used to prevent the rejection of transplanted organs) works.</p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, Ask your doctor or pharmacist for advice before taking this medicine.</p><p><strong>Driving and using machines</strong></p><p>Gloclav can have side effects and the symptoms may make you unfit to drive.</p><p>Do not drive or operate machinery unless you are feeling well.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take Gloclav exactly as your doctor or pharmacist has told you. You should check with your doctor or pharmacist if you are not sure.</p><p><strong>Adults and children weighing 40 kg and over</strong></p><p><strong>Gloclav 625 mg: </strong>The usual dose is one tablet three times a day.</p><p><strong>Children weighing less than 40 kg</strong></p><p>Children aged 6 years or less should preferably be treated with Gloclav oral suspension. Ask your doctor or pharmacist for advice when giving Gloclav tablets to children weighing less than 40 kg. The tablets are not suitable for children weighing less than 25 kg.</p><p><strong>Patients with kidney and liver problems</strong></p><p>&middot; If you have kidney problems the dose might be changed. A different strength or different medicine may be chosen by your doctor.</p><p>&middot; If you have liver problems you may have more frequent blood tests to check how your liver is working.</p><p><strong>How to take </strong><strong>Gloclav</strong></p><p>&middot; Take with a meal.</p><p>&middot; Swallow the tablets whole with a glass of water.</p><p>&middot; Space the doses evenly during the day. At least 4 hours apart.&nbsp; Do not take 2 doses in 1 hour.</p><p>&middot; Do not take<strong> </strong>Gloclav<strong><sup> </sup></strong>for more than 2 weeks. If you still feel unwell you should go back to see the doctor.</p><p><strong>If you take more Gloclav<sup> </sup>than you should</strong></p><p>If you take too much Gloclav, signs might include an upset stomach (feeling sick, being sick or diarrhoea) or convulsions. Talk to your doctor as soon as possible. Take the medicine carton or bottle to show the doctor.</p><p><strong>If you forget to take Gloclav</strong></p><p>&middot; If you forget to take a dose take it as soon as you remember.</p><p>&middot; You should not take the next dose too soon, but wait around 4 hours before taking the next dose. Do not take a double dose to make up for a forgotten dose.</p><p><strong>If you stop taking Gloclav</strong></p><p>Keep taking Gloclav until the treatment is finished, even if you feel better. You need every dose to help fight the infection. If some bacteria survive they can cause the infection to come back.<strong> </strong>If you have any further questions on the use of this product, ask your doctor or pharmacist.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>The side effects below may happen with this medicine.</p><p><strong>Conditions you need to look out for</strong> <strong>Allergic reactions:</strong></p><p>&middot; skin rash&nbsp;&nbsp;</p><p>&middot; inflammation of blood vessels (vasculitis) which may be visible as red or purple raised spots on the skin, but can affect other parts of the body</p><p>&middot; fever, joint pain, swollen glands in the neck, armpit or groin.</p><p>&middot; swelling, sometimes of the face or throat (angioedema), causing difficulty in breathing.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &middot; collapse.</p><p><strong>&rarr;Contact a doctor immediately </strong>if you get any of these symptoms. <strong>Stop taking Gloclav.</strong></p><p><strong>Inflammation of large intestine</strong></p><p>Inflammation of the large intestine, causing watery diarrhoea usually with blood and mucus, stomach pain and/or fever.</p><p><strong>&rarr;Contact your doctor as soon as possible </strong>for advice if you get these symptoms.</p><p><strong>Very common side effects (</strong>These may affect more than 1 in 10 people)</p><p>&middot; diarrhoea (in adults).</p><p><strong>Common side effects </strong>These may affect up to 1 in 10 people)</p><p>&middot; Thrush (candida - a yeast infection of the vagina, mouth or skin folds)</p><p>&middot; feeling sick (nausea), especially when taking high doses.</p><p>&rarr; if affected take Gloclav with meal.</p><p>&middot; vomiting&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>&middot;diarrhoea (in children).</p><p><strong>Uncommon side effects </strong>(These may affect up to 1 in 100 people)</p><p>&middot; skin rash, itching&nbsp;&nbsp;&nbsp;</p><p>&middot; raised itchy rash (hives)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>&middot; indigestion</p><p>&middot; dizziness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>&middot; headache.</p><p><strong>Uncommon side effects that may show up in your blood tests:</strong></p><p>&middot; increase in some substances (enzymes) produced by the liver.</p><p><strong>Rare side effects </strong>(These may affect up to 1 in 1000 people)</p><p>&middot; skin rash, which may blister, and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge &ndash; erythema multiforme).</p><p>&rarr; if you notice any of these symptoms contact a doctor urgently.</p><p><strong>Rare side effects that may show up in your blood tests:</strong></p><p>&middot; low number of cells involved in blood clotting&nbsp;</p><p>&middot; low number of white blood cells.</p><p><strong>Frequency not known</strong></p><p>Frequency cannot be estimated from the available data.</p><p>&middot; Allergic reactions (see above)</p><p>&middot; Inflammation of the large intestine (see above)</p><p>&middot; Inflammation of the protective membrane surrounding the brain (aseptic meningitis)&nbsp;</p><p>&middot; Serious skin reactions:</p><p>- a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (Stevens-Johnson syndrome), and a more severe form, causing extensive peeling of the skin (more than 30% of the body surface &ndash; toxic epidermal necrolysis)</p><p>- widespread red skin rash with small pus-containing blisters (bullous exfoliative dermatitis)</p><p>- a red, scaly rash with bumps under the skin and blisters (exanthemous pustulosis).</p><p>- flu-like symptoms with a rash, fever, swollen glands, and abnormal blood test results (including increased white blood cells (eosinophilia) and liver enzymes) (Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)).</p><p><strong>&rarr;Contact a doctor immediately if you get any of these symptoms.</strong></p><p>&middot; inflammation of the liver (hepatitis)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>&middot; jaundice, caused by increases in the blood of bilirubin (a substance produced in the liver) which may make your skin and whites of the eyes appear yellow&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>&middot; inflammation of tubes in the kidney</p><p>&middot; blood takes longer to clot&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>&middot; hyperactivity</p><p>&middot; convulsions (in people taking high doses of Gloclav or who have kidney problems).&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &middot; black tongue which looks hairy</p><p><strong>Side effects that may show up in your blood or urine tests:</strong></p><p>&middot; severe reduction in the number of white blood cells</p><p>&middot; low number of red blood cells (haemolytic anaemia)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>&middot; crystals in urine.</p><p><strong>If you get side effects, </strong>Tell your doctor or pharmacist<strong> </strong>if any of the side effects become<strong> severe or troublesome,</strong> or if<strong> </strong>you notice any side effects not listed in this leaflet</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep all medicines out of the sight and reach of children.</p><p>Do not store above 30&deg;C. Store in a dry place. Protect from light. Do not use Gloclav after the expiry date which is stated on the carton. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Gloclav 625mg: </strong>Each film coated tablet contains Amoxicillin Trihydrate USP equivalent to 500 mg of Amoxicillin and Potassium Clavulanate USP equivalent to 125 mg of Clavulanic acid.</p><p>&middot; The tablet excipients are magnesium stearate, sodium starch glycollate, colloidal anhydrous silica, microcrystalline cellulose.</p><p>&middot; The coating excipients are hypermellose E15, ethyl cellulose, propylene glycol, isopropyl alcohol<sup>*</sup>, opaspray K-1R-7000 white, dimeticone, methylene chloride<sup>*</sup>.</p><p><sup>*</sup>Not present in the final formulation, evaporates upon drying.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Gloclav 625mg: white to off white oval shaped, film-coated tablets with embossed GP15 on one side and plain on the other side. Gloclav 625mg film-coated tablets are packaged in blister packs of 20 tablets (10’s Blister X 2).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Globalpharma Co. LLC, P. O. Box 72168, Dubai, UAE</p><p>Tel: +97148090900, Email:&nbsp; info@globalpharma.ae</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in March2019 (RLD10/18)
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL"><strong>جلوكلاف</strong> هو مضاد حيوي ويعمل عن طريق قتل البكتيريا التي تسبب العدوى. ويحتوي هذا الدواء على دواءين مختلفين يدعيان أموكسيسيلّين &nbsp;&nbsp;وحمض الكلافيولنك. ينتمي أموكسيسيلّين إلى مجموعة من الأدوية تعرف بـ &quot;البنسلينات&quot; والتي من الممكن أن يتوقف عملها في بعض الأحيان (تصبح غير نشطة). تمنع المادة الفعالة الأخرى (حمض الكلافيولنك) حدوث ذلك.</p><p dir="RTL"><strong>يُستخدم جلوكلاف ٦</strong><strong>۲</strong><strong>٥ ملجم</strong> &nbsp;للمرضى البالغين والأطفال لعلاج العدوى التالية:</p><p dir="RTL">&bull; عدوى الأذن الوسطى والجيوب الأنفية</p><p dir="RTL">&bull; عدوى الجهاز التنفسي&nbsp;</p><p dir="RTL">&bull; عدوى المسالك البولية&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p dir="RTL">&bull; عدوى العظام والمفاصل.</p><p dir="RTL">&bull;عدوى الجلد والأنسجة الرخوة بما في ذلك عدوى الأسنان</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تتناول جلوكلاف:</strong></p><p dir="RTL">&bull; إذا كنت تعاني من حساسية تجاه أموكسيسيلّين ، أو حمض الكلافيولنك ، أو البنسلين أو أيًّ من مكونات جلوكلاف الأخرى (مدرجة في القسم ٦)</p><p dir="RTL">&bull; إذا كنت قد عانيت من قبل من تفاعل حساسية (فرط الحساسية) شديد تجاه أي مضاد حيوي آخر. وقد يشمل ذلك طفح جلدي أو تورم الوجه أو الحلق .</p><p dir="RTL">&bull; إذا كنت قد عانيت من قبل من مشاكل في الكبد أو من يرقان (اصفرار الجلد) عند تناول أحد المضادٍّات حيويٍّ.</p><p dir="RTL"><strong>&larr;لا تتناول جلوكلاف إذا كان ينطبق عليك أي مما سبق.</strong> إذا لم تكن متأكدًا، تحدث مع طبيبك&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;أو الصيدلي الخاص بك قبل تناول جلوكلاف.</p><p dir="RTL"><strong>تحذيرات وإحتياطات</strong></p><p dir="RTL">تحدث مع طبيبك أو الصيدلي الخاص بك قبل تناول هذا الدواء إذا كنت:</p><p dir="RTL">&bull; &bull;تعاني من حمى غدية</p><p dir="RTL">&bull; &nbsp;&bull;تُعالج من مشاكل بالكبد أو بالكلى</p><p dir="RTL">&bull; &bull;إذا كنت لا تتبول بصفة منتظمة.</p><p dir="RTL">إذا لم تكن متأكدًا مما إذا كان ينطبق عليك أي مما سبق، تحدث مع طبيبك أو الصيدلي الخاص بك قبل تناول جلوكلاف.</p><p dir="RTL">في بعض الحالات، قد يقوم طبيبك بفحص نوع البكتيريا المسببة للعدوى التي تعاني منها.</p><p dir="RTL">وبناءً على النتائج، قد يتم إعطاؤك جلوكلاف بتركيز مختلف أو يتم إعطاؤك دواءً مختلفًا.</p><p dir="RTL"><strong>الحالات التي يجب أن تنتبه لها</strong></p><p dir="RTL">قد يؤدي جلوكلاف<strong><sup> </sup></strong>إلى تدهور بعض الحالات القائمة، أو قد يسبب أعراضا جانبية. ويتضمن ذلك تفاعلات حساسية، تشنجات (نوبات تشنج) والتهاب الأمعاء الغليظة. يجب أن تنتبه لبعض الأعراض أثناء تناولك جلوكلاف؛ لتقليل خطر حدوث أية مشاكل. انظر &quot;الحالات التي يجب أن تنتبه لها&quot; في <strong>القسم ٤.</strong></p><p dir="RTL"><strong>اختبارات الدم والبول </strong></p><p dir="RTL">إذا كنت أجريت اختبارات دم (مثل اختبارات حالة خلايا الدم الحمراء أو اختبارات وظائف الكبد)،</p><p dir="RTL">&nbsp;أو اختبارات بول (للكشف عن وجود الجلوكوز)، فأخبر الطبيب أو الممرضة بأنك تتناول جلوكلاف.</p><p dir="RTL">&nbsp;وهذا لأن جلوكلاف قد يؤثر على نتيجة هذه الأنواع من الاختبارات.</p><p dir="RTL"><strong>تناول أدوية أخرى مع جلوكلاف</strong></p><p dir="RTL">يُرجى إبلاغ طبيبك أو الصيدلي الخاص بك إذا كنت تتناول أو قد تناولت مؤخرًا أو قد تتناول أيَّة أدوية أخرى. يشمل ذلك الأدوية التي يمكن شراؤها بدون وصفة طبية والأدوية العشبية.</p><p dir="RTL">&bull; إذا كنت تتناول ألوبيورينول (دواء يستخدم لعلاج مرض النقرس) مع جلوكلاف<strong><sup> </sup></strong>، فيحتمل بدرجة أكبر أن تصاب بأحد تفاعلات الحساسية بالجلد.</p><p dir="RTL">&bull; إذا كنت تتناول بروبينيسيد (دواء يستخدم لعلاج مرض النقرس) ، فقد يقرر طبيبك تعديل &nbsp;جرعتك من جلوكلاف.</p><p dir="RTL">&bull; في حالة تناول أدوية تساعد على منع تجلط الدم (مثل وارفارين( مع جلوكلاف، قد يكون من الضروري إجراء المزيد من اختبارات الدم.</p><p dir="RTL">&bull; من الممكن أن يؤثر جلوكلاف<sup> </sup>على طريقة عمل ميثوتريكسات (دواء يستخدم لعلاج السرطان&nbsp;&nbsp;&nbsp; &nbsp;أو الأمراض الروماتيزمية).</p><p dir="RTL">&bull; من الممكن أن يؤثر جلوكلاف<strong><sup> </sup></strong>على طريقة عمل ميكوفينولايت موفيتيل (دواء يعمل على منع رفض الجسم للأعضاء المزروعة).</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية والخصوبة</strong></p><p dir="RTL">إذا كنتِ حاملًا أو مرضعًا، أو تعتقدين أنكِ حامل أو تخططين للحمل، فاستشيري طبيبك أو الصيدلي الخاص بك قبل استخدام هذا الدَّواء.</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">قد يكون لـ جلوكلاف<strong><sup> </sup></strong><sup>&nbsp;</sup>أعراضا جانبية وقد تجعلك الأعراض غير قادر على القيادة.</p><p>لا تقم بالقيادة أو تشغيل الآلات ما لم تشعر بأنك على ما يرام</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تناول جلوكلاف دائما كما أخبرك طبيبك أو الصيدلي الخاص بك. يجب مراجعة طبيبك أو الصيدلي الخاص بك إذا لم تكن متأكدًا.</p><p dir="RTL"><strong>البالغون والأطفال الذين تبلغ أوزانهم ٤٠ كجم فأكثر</strong></p><p dir="RTL"><strong>جلوكلاف ٦۲٥ ملجم &nbsp;: </strong>الجرعة المعتادة هي قرص واحد ثلاث مرات يوميًّا</p><p dir="RTL"><strong>الأطفال الذين تقل أوزانهم عن ٤٠ كجم</strong></p><p dir="RTL">الأطفال الذين تبلغ أعمارهم ستة أعوام أو أقل يفضل معالجتهم&nbsp; بمعلق جلوكلاف عن طريق الفم.</p><p dir="RTL">إستشر طبيبك او الصيدلي الخاص بك قبل إعطاء أقراص جلوكلاف للأطفال الذين تقل أوزانهم عن ٤٠ كجم . ينصح بعدم إعطاء الأقراص للأطفال الذين تقل أوزانهم عن ۲٥ كجم لانها لا تناسبهم.</p><p dir="RTL"><strong>المرضى الذين يعانون من مشاكل في الكلى والكبد </strong></p><p dir="RTL">&bull; ربما تتغير الجرعة إذا كنت تعاني من مشاكل في الكلى. قد يختار طبيبك تركيزًا أو دواءً مختلفًا.</p><p dir="RTL">&bull; إذا كنت تعاني من مشاكل في الكبد فقد ينبغي عليك إجراء اختبارات دم متعددة للتأكد من أن الكبد يعمل بشكل سليم.</p><p dir="RTL"><strong>كيفية تناول </strong><strong>جلوكلاف</strong></p><p dir="RTL">&bull; تناوله أثناء تناولك إحدى وجبات الطعام.</p><p dir="RTL">&bull; ابتلع الأقراص كاملة مع كوب من الماء .</p><p dir="RTL">&bull; قم بالفصل بين الجرعات بفترات متساوية على مدى اليوم بأربع ساعات على الأقل.</p><p dir="RTL">&nbsp;لا تتناول جرعتين في غضون ساعة واحدة.</p><p dir="RTL">&bull; لا تتناول جلوكلاف<strong><sup> </sup></strong>لأكثر من أسبوعين . في حالة استمرار شعورك بأنك لست على ما يرام فيجب عليك أن تراجع الطبيب.</p><p dir="RTL"><strong>إذا تناولت جرعة زائدة من </strong><strong>جلوكلاف </strong></p><p dir="RTL">إذا تناولت كمية أكثر مما يجب من جلوكلاف ، فقد تشمل العلامات اضطراب المعدة (الشعور بالإعياء أو الإعياء بالفعل أو الإسهال) أو التشنجات. تحدث مع طبيبك في أسرع وقت ممكن. أصطحب معك زجاجة أو عبوة الدواء؛ لعرضها على الطبيب.</p><p dir="RTL"><strong>إذا نسيت تناول </strong><strong>جلوكلاف</strong></p><p dir="RTL">&bull; إذا نسيت تناول جرعة فتناولها بمجرد أن تتذكرها.</p><p dir="RTL">&bull; يجب ألا تتناول الجرعة التالية بشكل مبكر، ولكن انتظر ٤ ساعات تقريبًا قبل تناول الجرعة التالية. لا تتناول جرعة مضاعفة لتعويض الجرعة الفائتة.</p><p dir="RTL">&nbsp;<strong>إذا توقفت عن تناول جلوكلاف</strong></p><p dir="RTL">استمر في تناول جلوكلاف<strong><sup> </sup></strong>حتى إنتهاء العلاج، حتى إذا شعرت بتحسن. أنت في حاجة لكل جرعة للمساعدة في مكافحة العدوى. إن بقاء بعض البكتيريا حية قد يؤدي إلى عودة العدوى.</p><p dir="RTL">إذا كانت لديك أية أسئلة إضافية حول استخدام هذا المنتج، فاستشر طبيبك أو الصيدلي الخاص بك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثله مثل كافة الأدوية، قد يُسبب هذا الدَّواء تأثيرات جانبية، على الرَّغم من عدم حدوثها لدى الجميع. قد تُصاب بالتأثيرات الجانبية أدناه بمصاحبة هذا الدَّواء.</p><p dir="RTL"><strong>الحالات التي يجب أن تنتبه لها تفاعلات الحساسية:</strong></p><p dir="RTL">&bull; الطفح الجلدي&nbsp;&nbsp;&nbsp;</p><p dir="RTL">&bull; التهاب الأوعية الدموية والذي قد يظهر في هيئة بقع حمراء أو أرجوانية بارزة على الجلد، ولكن قد تؤثر على أجزاء أخرى من الجسم.</p><p dir="RTL">&bull; حمى أو ألم بالمفاصل أو تورم الغدد في العنق، الإبط أو الأربية.</p><p dir="RTL">&bull; تورم، في بعض الأحيان بالوجه أو الحلق (وذمة وعائية) ، يسبب صعوبة في التنفس</p><p dir="RTL">&bull; انهيار (إغماء).</p><p dir="RTL"><strong>&larr;اتصل بالطبيب فورًا</strong> إذا عانيت من أيٍّ من هذه التأثيرات. <strong>توقف عن تناول جلوكلاف.</strong></p><p dir="RTL"><strong>التهاب الأمعاء الغليظة</strong></p><p dir="RTL">التهاب الأمعاء الغليظة، والذي يسبب إسهال سائلا مصحوبًا عادة بدم ومخاط، وألم في المعدة و/أو حمى.</p><p dir="RTL"><strong>&larr;استشر طبيبك بأسرع ما يمكن</strong> إذا عانيت من هذه الأعراض.</p><p dir="RTL"><strong>تأثيرات جانبية شائعة جدًّا</strong></p><p dir="RTL">قد تؤثر في أكثر من شخص واحد من بين كل ۱٠ أشخاص</p><p dir="RTL">&bull; إسهال (في البالغين).</p><p dir="RTL"><strong>تأثيرات جانبية شائعة</strong></p><p dir="RTL">قد تُؤثر في ما يصل إلى شخص واحد من بين كل ۱٠ أشخاص:</p><p dir="RTL">&bull; مرض المبيضات الفموي &quot;سلاق&quot; (مبيضات &ndash; عدوى بالخمائر في المهبل أو الفم أو طيات الجلد)</p><p dir="RTL">&bull; الشعور بالإعياء (غثيان) ، خاصة عند تناول جرعات مرتفعة.</p><p dir="RTL">&larr; إذا تعرضت لذلك، تناول جلوكلاف أثناء إحدى وجبات الطعام.</p><p dir="RTL">&bull; قيء&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p dir="RTL">&bull; إسهال (في الأطفال).</p><p dir="RTL"><strong>تأثيرات جانبية غير شائعة</strong></p><p dir="RTL">قد تؤثر فيما يصل إلى شخص واحد من بين كل ۱٠٠ شخص:</p><p dir="RTL">&bull; طفح جلدي، حكة&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; طفح جلدي بارز مصحوب بحكة (شرى)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; عسر الهضم</p><p dir="RTL">&bull; دوخة&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; صداع.</p><p dir="RTL"><strong>تأثيرات جانبية غير شائعة قد تظهر في اختبارات الدم لديك:</strong></p><p dir="RTL">&bull; زيادة في بعض المواد (إنزيمات) التي ينتجها الكبد.</p><p dir="RTL"><strong>تأثيرات جانبية نادرة</strong></p><p dir="RTL">قد تؤثر فيما يصل إلى شخص واحد من بين كل ۱٠٠٠ شخص:</p><p dir="RTL">&bull;&nbsp; طفح جلدي قد يُسبب بثورًا، ويبدو كبقع صغيرة (بقع مُتَوَسّطة داكنة محاطة بمنطقة أكثر شحوبًا تصاحبها حلقة داكنة حول الحافة -احمرار متعدد الأشكال).&nbsp;</p><p dir="RTL">&larr; إذا لاحظت أي من هذه الأعراض فاتصل بطبيبك على وجه السرعة.</p><p dir="RTL"><strong>تأثيرات جانبية نادرة قد تظهر في اختبارات الدم لديك:</strong></p><p dir="RTL">&bull; انخفاض عدد خلايا الدم المرتبطة بتجلط الدم.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; انخفاض عدد خلايا الدم البيضاء.</p><p dir="RTL"><strong>تأثيرات جانبية غير معروف نسبة تكرارها</strong></p><p dir="RTL">لا يمكن معرفة نسبة تكراها من المعلومات المتاحة</p><p dir="RTL">ظهرت أعراض جانبية أخرى لعدد قليل جدًّا من الأشخاص ولكن معدل حدوثها غير معروف</p><p dir="RTL">&bull; تفاعلات حساسية (انظر أعلاه)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; التهاب الأمعاء الغليظة (انظر أعلاه)</p><p dir="RTL">&bull; التهاب الغشاء الواقي المحيط بالمخ (التهاب السحايا غير الصديدي)</p><p dir="RTL">&bull; تفاعلات جلدية خطيرة:</p><p dir="RTL">- طفح جلدي واسع الانتشار يصاحبه بثور وتقشر بالجلد، لا سيما حول الفم والأنف والعينين والأعضاء التناسلية (متلازمة ستيفنز جونسون)، وشكل أكثر حدة يُسبب تقشر الجلد بشكل مكثف (أكثر من ٣٠٪ من سطح الجلد - انحلال البشرة النخري التَّسَمُّمِيّ).</p><p dir="RTL">- طفح جلدي أحمر واسع الانتشار يصاحبه بثور صغير تحتوي على الصديد (التهاب الجلد التقشري الفقاعي).</p><p dir="RTL">- طفح جلدي أحمر ومتقشر مع نتوءات تحت الجلد وبثور (طفح جلدي ظاهري صديدي).</p><p dir="RTL">- أعراض شبيهة بأعراض الأنفلونزا مصحوبة بطفح جلدي، حُمى، تورم الغدد، ونتائج غير طبيعية في اختبارات الدَّم (بما في ذلك زيادة خلايا الدَّم البيضاء (كثرة خلايا اليُوزينِيَّات) وإنزيمات الكبد) (الطفح الجلدي التفاعلي الدوائي المصحوب بكثرة خلايا اليُوزينِيَّات والأعراض الجهازية (DRESS)).</p><p dir="RTL"><strong>&larr;اتصل بالطبيب فورًا إذا عانيت من أيٍّ من هذه التأثيرات</strong>.</p><p dir="RTL">&bull; التهاب كبدي</p><p dir="RTL">&bull; يرقان، ناتج عن زيادة نسبة البيليروبين في الدم (مادة يتم إنتاجها في الكبد) والتي قد تجعل من جلدك وبياض عينيك يبدو لونهما أصفر</p><p dir="RTL">&bull; التهاب النُّبَيباتُ الكُلْوِيَّة&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p dir="RTL">&bull; استغراق الدم وقت أطول في التخثر&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p dir="RTL">&bull; فرط النشاط&nbsp;&nbsp;&nbsp;</p><p dir="RTL">&bull; تشنجات (لدى الأشخاص الذين يتناولون جرعات مرتفعة من جلوكلاف أو الذين يعانون من مشاكل في الكلى)</p><p dir="RTL">&bull; تلون اللسان بلون أسود ليبدو وكأنه مشعر.</p><p dir="RTL"><strong>تأثيرات</strong><strong> جانبية قد تظهر في اختبارات الدم أو البول:</strong></p><p dir="RTL">&bull; انخفاض شديد في عدد خلايا الدم البيضاء</p><p dir="RTL">&bull; انخفاض عدد كريات الدم الحمراء (فقر الدم الانحلالي) [أنيميا حالـَّة للدم</p><p dir="RTL">&bull; تكون بلورات في البول.</p><p dir="RTL"><strong>يُرجى إبلاغ طبيبك أو الصيدلي الخاص بك</strong> إذا أصبح أي من الأعراض الجانبية شديدًا أو أصبح مزعجًا أو إذا لاحظت أية أعراض جانبية غير المذكورة في هذه النشرة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تحفظ الأدوية بعيدا عن رؤية ومتناول الأطفال<sup> </sup>. <sup>&nbsp;</sup>يحفظ في &nbsp;درجة حرارة لا تزيد عن ۳۰ درجة مئوية في مكان جاف بعيدا عن الضوء . لا تستخدم جلوكلاف بعد تاريخ انتهاء الصلاحية المدون على العبوة.</p><p dir="RTL">&nbsp;يجب عدم التخلص من الأدوية عن طريق إلقائها في مياه الصرف أو مع المخلفات المنزلية. استفسر من الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&nbsp;</p><p dir="RTL"><strong>جلوكلاف&nbsp; ٦۲٥ملجم:</strong> يحتوي كل قرص مغلف على أموكسيسلّين ثلاثي الهيدرات ( طبقا لدستور الأدوية الأمريكي) مكافئ لـ ٥۰۰ ملجم أموكسيسيلّين &nbsp;و كلافيولانات البوتاسيوم( طبقا لدستور الأدوية الأمريكي )</p><p dir="RTL">مكافئ لـ ۱۲٥ ملجم حمض الكلافيولنك .</p><p dir="RTL">&bull; المواد غير الفعالة بالقرص هي ستيرات الماغنسيوم، جليكولات نشا الصوديوم، سيليكا غروية لا مائية، سليلوز فائق التبلور<em>. </em></p><p dir="RTL">&bull; المواد غير الفعالة بغلاف القرص هي هيبروميلوز E15، إيثيل سليلوز، بروبيلين جلايكول، أيزوبروبيل الكحول*، أوباسبراي أبيض K-1R-7000، ديميتيكون، ميثيلين كلورايد*.</p><p dir="RTL">*غير موجود في التركيبة النهائيه لغلاف القرص بسبب تبخره.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>جلوكلاف<sup> </sup></strong><strong>٦</strong><strong>۲٥ ملجم: </strong>أقراص مغلفة بيضاوية الشكل يميل لونها بين الأبيض والأبيض المائل للصفرة محفور على أحد جانبيها <strong>GP15</strong> والجانب الآخر خال من الحفر.<strong> </strong>أقراص جلوكلاف<sup> </sup>٦۲٥ ملجم المغلفة تعبأ في أشرطة داخل عبوات تحتوي على<strong> </strong>۲۰ قرص ( شريطان بكل منهما ۱۰ أقراص ).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شركة جلوبال فارما ذ.م.م. ، ص.ب. ۷۲۱٦٨ ، دبي ، الامارات العربية المتحدة .</p><p dir="RTL">هاتف: /٩٧١٤٨٠٩٠٩٠٠+/&nbsp; ، بريد إلكتروني: info@globalpharma.ae</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تم آخر تحديث لهذه النشرة في مارس ۲۰۱٩ ( RLD10/18 )
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gloclav 625 mg Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each film coated tablet contains amoxicillin trihydrate USP equivalent to 500 mg of amoxicillin and potassium clavulanate USP equivalent to 125 mg of clavulanic acid. 
For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablet
White to off white oval shaped, film-coated tablets with embossed GP15 on one side and plain on the other side.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Gloclav is indicated for the treatment of the following infections in adults and children (see sections 4.2, 4.4 and 5.1):</p><p>&bull; Acute bacterial sinusitis (adequately diagnosed)</p><p>&bull; Acute otitis media</p><p>&bull; Acute exacerbations of chronic bronchitis (adequately diagnosed)</p><p>&bull; Community acquired pneumonia</p><p>&bull; Cystitis</p><p>&bull; Pyelonephritis</p><p>&bull; Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis.</p><p>&bull; Bone and joint infections, in particular osteomyelitis.</p><p>Consideration should be given to official guidance on the appropriate use of antibacterial agents.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u></p><p>Doses are expressed throughout in terms of amoxicillin/clavulanic acid content except when doses are stated in terms of an individual component.</p><p>The dose of Gloclav that is selected to treat an individual infection should take into account:</p><p>&bull; The expected pathogens and their likely susceptibility to antibacterial agents (see section 4.4)</p><p>&bull; The severity and the site of the infection</p><p>&bull; The age, weight and renal function of the patient as shown below.</p><p>The use of alternative presentations of Gloclav (e.g. those that provide higher doses of amoxicillin and/or different ratios of amoxicillin to clavulanic acid) should be considered as necessary (see sections 4.4 and 5.1).</p><p>For adults and children &ge; 40 kg, this formulation of Gloclav provides a total daily dose of 1500 mg amoxicillin/375 mg clavulanic acid, when administered as recommended below. For children &lt; 40 kg, this formulation of Gloclav provides a maximum daily dose of 2400 mg amoxicillin/600 mg clavulanic acid, when administered as recommended below. If it is considered that a higher daily dose of amoxicillin is required, it is recommended that another preparation of Gloclav is selected in order to avoid administration of unnecessarily high daily doses of clavulanic acid (see sections 4.4 and 5.1).</p><p>The duration of therapy should be determined by the response of the patient. Some infections (e.g. osteomyelitis) require longer periods of treatment. Treatment should not be extended beyond 14 days without review (see section 4.4 regarding prolonged therapy).</p><p><u>Adults and children &ge; 40 kg</u></p><p>One 500 mg/125 mg dose taken three times a day.</p><p><u>Children &lt; 40 kg</u></p><p>20 mg/5 mg/kg/day to 60 mg/15 mg/kg/day given in three divided doses.</p><p>Children may be treated with Gloclav tablets or suspensions.</p><p>As the tablets cannot be divided, children weighing less than 25 kg must not be treated with Gloclav tablets.</p><p>The table below presents the received dose (mg/kg body weight) in children weighing 25 kg to 40 kg upon administering a single 500/125 mg tablet.</p><table border="1" cellspacing="0" cellpadding="0" style="width:691px"><tbody><tr><td style="vertical-align:top"><p>Body weight [kg]</p></td><td style="vertical-align:top"><p>40</p></td><td style="vertical-align:top"><p>35</p></td><td style="vertical-align:top"><p>30</p></td><td style="vertical-align:top"><p>25</p></td><td style="vertical-align:top"><p>Single dose recommended [mg/kg body weight] (see above)</p></td></tr><tr><td style="vertical-align:top"><p>Amoxicillin [mg/kg body weight] per single dose (1 film-coated tablet)</p></td><td style="vertical-align:top"><p>12.5</p></td><td style="vertical-align:top"><p>14.3</p></td><td style="vertical-align:top"><p>16.7</p></td><td style="vertical-align:top"><p>20.0</p></td><td style="vertical-align:top"><p>6.67 &ndash; 20</p></td></tr><tr><td style="vertical-align:top"><p>Clavulanic acid [mg/kg body weight] per single dose (1 film-coated tablet)</p></td><td style="vertical-align:top"><p>3.1</p></td><td style="vertical-align:top"><p>3.6</p></td><td style="vertical-align:top"><p>4.2</p></td><td style="vertical-align:top"><p>5.0</p></td><td style="vertical-align:top"><p>1.67 - 5</p></td></tr></tbody></table><p>Children aged 6 years and below or weighing less than 25 kg should preferably be treated with Gloclav suspension.</p><p>No clinical data are available on doses of amoxicillin/clavulanic acid 4:1 formulations higher than 40 mg/10 mg/kg per day in children under 2 years.</p><p><u>Elderly</u></p><p>No dose adjustment is considered necessary.</p><p><u>Renal impairment</u></p><p>Dose adjustments are based on the maximum recommended level of amoxicillin.</p><p>No adjustment in dose is required in patients with creatinine clearance (CrCl) greater than 30 ml/min.</p><p><em>Adults and children &ge; 40 kg</em></p><table border="1" cellspacing="0" cellpadding="0" style="width:691px"><tbody><tr><td style="vertical-align:top"><p>CrCl: 10-30 ml/min</p></td><td style="vertical-align:top"><p>500 mg/125 mg twice daily</p></td></tr><tr><td style="vertical-align:top"><p>CrCl &lt; 10 ml /min</p></td><td style="vertical-align:top"><p>500 mg/125 mg once daily</p></td></tr><tr><td style="vertical-align:top"><p>Haemodialysis</p></td><td style="vertical-align:top"><p>500 mg/125 mg every 24 hours, plus 500 mg/125 mg during dialysis, to be repeated at the end of dialysis (as serum concentrations of both amoxicillin and clavulanic acid are decreased)</p></td></tr></tbody></table><p><em>Children &lt; 40 kg</em></p><table border="1" cellspacing="0" cellpadding="0" style="width:691px"><tbody><tr><td style="vertical-align:top"><p>CrCl: 10-30 ml/min</p></td><td style="vertical-align:top"><p>15 mg/3.75 mg/kg twice daily<strong>&nbsp;</strong>(maximum 500 mg/125 mg twice daily).</p></td></tr><tr><td style="vertical-align:top"><p>CrCl &lt; 10 ml /min</p></td><td style="vertical-align:top"><p>15 mg/3.75 mg/kg as a single daily dose<strong>&nbsp;</strong>(maximum 500 mg/125 mg).</p></td></tr><tr><td style="vertical-align:top"><p>Haemodialysis</p></td><td style="vertical-align:top"><p>15 mg/3.75 mg/kg per day once daily.</p><p>Prior to haemodialysis 15 mg/3.75 mg/kg. In order to restore circulating drug levels, 15 mg/3.75 mg per kg should be administered after haemodialysis.</p></td></tr></tbody></table><p><u>Hepatic impairment</u></p><p>Dose with caution and monitor hepatic function at regular intervals (see sections 4.3 and 4.4).</p><p><u>Method of administration</u></p><p>Gloclav is for oral use.</p><p>Gloclav should be administered with a meal to minimise potential gastrointestinal intolerance.</p><p>Therapy can be started parenterally according the SPC of the IV formulation and continued with an oral preparation.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substances, to any of the penicillins or to any of the excipients listed in section 6.1.
History of a severe immediate hypersensitivity reaction (e.g. anaphylaxis) to another beta-lactam agent (e.g. a cephalosporin, carbapenem or monobactam).
History of jaundice/hepatic impairment due to amoxicillin/clavulanic acid (see section 4.8).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Before initiating therapy with amoxicillin/clavulanic acid, careful enquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalosporins or other beta-lactam agents (see sections 4.3 and 4.8).</p><p>Serious and occasionally fatal hypersensitivity hypersensitivity reactions (including anaphylactoid and severe cutaneous adverse reactions) have been reported in patients on penicillin therapy. These reactions are more likely to occur in individuals with a history of penicillin hypersensitivity and in atopic individuals. If an allergic reaction occurs, amoxicillin/clavulanic acid therapy must be discontinued and appropriate alternative therapy instituted.</p><p>In the case that an infection is proven to be due to an amoxicillin-susceptible organisms(s) then consideration should be given to switching from amoxicillin/clavulanic acid to amoxicillin in accordance with official guidance.</p><p>This presentation of Gloclav is not suitable for use when there is a high risk that the presumptive pathogens have reduced susceptibility or resistance to beta-lactam agents that is not mediated by beta-lactamases susceptible to inhibition by clavulanic acid. This presentation should not be used to treat penicillin-resistant&nbsp;<em>S. pneumoniae</em>.</p><p>Convulsions may occur in patients with impaired renal function or in those receiving high doses (see section 4.8).</p><p>Amoxicillin/clavulanic acid should be avoided if infectious mononucleosis is suspected since the occurrence of a morbilliform rash has been associated with this condition following the use of amoxicillin.</p><p>Concomitant use of allopurinol during treatment with amoxicillin can increase the likelihood of allergic skin reactions.</p><p>Prolonged use may occasionally result in overgrowth of non-susceptible organisms.</p><p>The occurrence at the treatment initiation of a feverish generalised erythema associated with pustula may be a symptom of acute generalised exanthemous pustulosis (AGEP) (see section 4.8). This reaction requires Gloclav discontinuation and contraindicates any subsequent administration of amoxicillin.</p><p>Amoxicillin/clavulanic acid should be used with caution in patients with evidence of hepatic impairment (see sections 4.2, 4.3 and 4.8).</p><p>Hepatic events have been reported predominantly in males and elderly patients and may be associated with prolonged treatment. These events have been very rarely reported in children. In all populations, signs and symptoms usually occur during or shortly after treatment but in some cases may not become apparent until several weeks after treatment has ceased. These are usually reversible. Hepatic events may be severe and, in extremely rare circumstances deaths have been reported. These have almost always occurred in patients with serious underlying disease or taking concomitant medications known to have the potential for hepatic effects (see section 4.8).</p><p>Antibiotic-associated colitis has been reported with nearly all antibacterial agents including amoxicillin and may range in severity from mild to life threatening (see section 4.8). Therefore, it is important to consider this diagnosis in patients who present with diarrhoea during or subsequent to the administration of any antibiotics. Should antibiotic-associated colitis occur, amoxicillin/clavulanic acid should immediately be discontinued, a physician be consulted and an appropriate therapy initiated. Anti-peristaltic medicinal products are contraindicated in this situation.</p><p>Periodic assessment of organ system functions, including renal, hepatic and haematopoietic function is advisable during prolonged therapy.</p><p>Prolongation of prothrombin time has been reported rarely in patients receiving amoxicillin/clavulanic acid. Appropriate monitoring should be undertaken when anticoagulants are prescribed concomitantly. Adjustments in the dose of oral anticoagulants may be necessary to maintain the desired level of anticoagulation (see sections 4.5 and 4.8).</p><p>In patients with renal impairment, the dose should be adjusted according to the degree of impairment (see section 4.2).</p><p>In patients with reduced urine output, crystalluria has been observed very rarely, predominantly with parenteral therapy. During the administration of high doses of amoxicillin, it is advisable to maintain adequate fluid intake and urinary output in order to reduce the possibility of amoxicillin crystalluria. In patients with bladder catheters, a regular check of patency should be maintained (see section 4.9).</p><p>During treatment with amoxicillin, enzymatic glucose oxidase methods should be used whenever testing for the presence of glucose in urine because false positive results may occur with non-enzymatic methods.</p><p>The presence of clavulanic acid in Gloclav may cause a non-specific binding of IgG and albumin by red cell membranes leading to a false positive Coombs test.</p><p>There have been reports of positive test results using the Bio-Rad Laboratories Platelia&nbsp;<em>Aspergillus</em>&nbsp;EIA test in patients receiving amoxicillin/clavulanic acid who were subsequently found to be free of&nbsp;<em>Aspergillus</em>&nbsp;infection. Cross-reactions with non-<em>Aspergillus</em>polysaccharides and polyfuranoses with Bio-Rad Laboratories Platelia&nbsp;<em>Aspergillus</em>&nbsp;EIA test have been reported. Therefore, positive test results in patients receiving amoxicillin/clavulanic acid should be interpreted cautiously and confirmed by other diagnostic methods.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Oral anticoagulants</u></p><p>Oral anticoagulants and penicillin antibiotics have been widely used in practice without reports of interaction. However, in the literature there are cases of increased international normalised ratio in patients maintained on acenocoumarol or warfarin and prescribed a course of amoxicillin. If co-administration is necessary, the prothrombin time or international normalised ratio should be carefully monitored with the addition or withdrawal of amoxicillin. Moreover, adjustments in the dose of oral anticoagulants may be necessary (see sections 4.4 and 4.8).</p><p><u>Methotrexate</u></p><p>Penicillins may reduce the excretion of methotrexate causing a potential increase in toxicity.</p><p><u>Probenecid</u></p><p>Concomitant use of probenecid is not recommended. Probenecid decreases the renal tubular secretion of amoxicillin. Concomitant use of probenecid may result in increased and prolonged blood levels of amoxicillin but not of clavulanic acid.</p><p><u>Mycophenolate mofetil</u></p><p>In patients receiving mycophenolate mofetil, reduction in pre-dose concentration of the active metabolite mycophenolic acid (MPA) of approximately 50% has been reported following commencement of oral amoxicillin plus clavulanic acid. The change in pre-dose level may not accurately represent changes in overall MPA exposure. Therefore, a change in the dose of mycophenolate mofetil should not normally be necessary in the absence of clinical evidence of graft dysfunction. However, close clinical monitoring should be performed during the combination and shortly after antibiotic treatment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development (see section 5.3). Limited data on the use of amoxicillin/clavulanic acid during pregnancy in humans do not indicate an increased risk of congenital malformations. In a single study in women with preterm, premature rupture of the foetal membrane it was reported that prophylactic treatment with amoxicillin/clavulanic acid may be associated with an increased risk of necrotising enterocolitis in neonates. Use should be avoided during pregnancy, unless considered essential by the physician.</p><p><u>Breastfeeding</u></p><p>Both substances are excreted into breast milk (nothing is known of the effects of clavulanic acid on the breast-fed infant). Consequently, diarrhoea and fungus infection of the mucous membranes are possible in the breast-fed infant, so that breast-feeding might have to be discontinued. The possibility of sensitisation should be taken into account. Amoxicillin/clavulanic acid should only be used during breast-feeding after benefit/risk assessment by the physician in charge.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects on the ability to drive and use machines have been performed. However, undesirable effects may occur (e.g. allergic reactions, dizziness, convulsions), which may influence the ability to drive and use machines (see section 4.8).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The most commonly reported adverse drug reactions (ADRs) are diarrhoea, nausea and vomiting.</p><p>The ADRs derived from clinical studies and post-marketing surveillance with Gloclav, sorted by MedDRA System Organ Class are listed below.</p><p>The following terminologies have been used in order to classify the occurrence of undesirable effects.</p><p>Very common (&ge;1/10)</p><p>Common (&ge;1/100 to &lt;1/10)</p><p>Uncommon (&ge;1/1,000 to &lt;1/100)</p><p>Rare (&ge;1/10,000 to &lt;1/1,000)</p><p>Very rare (&lt;1/10,000)</p><p>Not known (cannot be estimated from the available data)</p><table border="1" cellspacing="0" cellpadding="0" style="width:691px"><tbody><tr><td colspan="2" style="vertical-align:top"><p><u>Infections and infestations</u></p></td></tr><tr><td style="vertical-align:top"><p>Mucocutaneous candidosis</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Overgrowth of non-susceptible organisms</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Blood and lymphatic system disorders</u></p></td></tr><tr><td style="vertical-align:top"><p>Reversible leucopenia (including neutropenia)</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Thrombocytopenia</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Reversible agranulocytosis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Haemolytic anaemia</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Prolongation of bleeding time and prothrombin time<sup>1</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Immune system disorders</u><sup>10</sup></p></td></tr><tr><td style="vertical-align:top"><p>Angioneurotic oedema</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Anaphylaxis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Serum sickness-like syndrome</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Hypersensitivity vasculitis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Nervous system disorders</u></p></td></tr><tr><td style="vertical-align:top"><p>Dizziness</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Headache</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Reversible hyperactivity</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Convulsions<sup>2</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Aeseptic meningitis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Gastrointestinal disorders</u></p></td></tr><tr><td style="vertical-align:top"><p>Diarrhoea</p></td><td style="vertical-align:top"><p>Very common</p></td></tr><tr><td style="vertical-align:top"><p>Nausea<sup>3</sup></p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Vomiting</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Indigestion</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Antibiotic-associated colitis<sup>4</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Black hairy tongue</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Hepatobiliary disorders</u></p></td></tr><tr><td style="vertical-align:top"><p>Rises in AST and/or ALT<sup>5</sup></p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Hepatitis<sup>6</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Cholestatic jaundice<sup>6</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Skin and subcutaneous tissue disorders</u><u><sup>7</sup></u></p></td></tr><tr><td style="vertical-align:top"><p>Skin rash</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Pruritus</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Urticaria</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Erythema multiforme</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Stevens-Johnson syndrome</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Toxic epidermal necrolysis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Bullous exfoliative-dermatitis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Acute generalised exanthemous pustulosis (AGEP)<sup>9</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Drug reaction with eosinophilia and systemic symptoms (DRESS)</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Renal and urinary disorders</u></p></td></tr><tr><td style="vertical-align:top"><p>Interstitial nephritis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Crystalluria<sup>8</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><sup>1</sup>&nbsp;See section 4.4</p><p><sup>2</sup>&nbsp;See section 4.4</p><p><sup>3</sup>&nbsp;Nausea is more often associated with higher oral doses. If gastrointestinal reactions are evident, they may be reduced by taking amoxicillin/clavulanic acid with a meal.</p><p><sup>4&nbsp;</sup>Including pseudomembranous colitis and haemorrhagic colitis (see section 4.4)</p><p><sup>5</sup>&nbsp;A moderate rise in AST and/or ALT has been noted in patients treated with beta-lactam class antibiotics, but the significance of these findings is unknown.</p><p><sup>6&nbsp;</sup>These events have been noted with other penicillins and cephalosporins (see section 4.4).</p><p><sup>7</sup>&nbsp;If any hypersensitivity dermatitis reaction occurs, treatment should be discontinued (see section 4.4).</p><p><sup>8</sup>&nbsp;See section 4.9</p><p><sup>9</sup>&nbsp;See section 4.4</p><p><sup>10</sup>&nbsp;See sections 4.3 and 4.4</p></td></tr></tbody></table><p><u>&nbsp;</u></p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important.</p><p>It allows continued monitoring of the benefit/risk balance of the medicinal product.</p><p>Healthcare professionals are asked to report any suspected adverse reactions at:</p><p><strong>&bull; Saudi Arabia:</strong></p><p>The National Pharmacovigilance and Drug Safety Centre (NPC), Fax: +966-11-205-7662,</p><p>Call NPC at +966-11-2038222, Exts 2317-2356-2340. Reporting Hotline: 19999,</p><p>E-mail: npc.drug@sfda.gov.sa , Website: www.sfda.gov.sa/npc</p><p><strong>&bull; Other GCC States:</strong></p><p>Please contact the relevant competent authority</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Symptoms and signs of overdose</u></p><p>Gastrointestinal symptoms and disturbance of the fluid and electrolyte balances may be evident. Amoxicillin crystalluria, in some cases leading to renal failure, has been observed (see section 4.4).</p><p>Convulsions may occur in patients with impaired renal function or in those receiving high doses.</p><p>Amoxicillin has been reported to precipitate in bladder catheters, predominantly after intravenous administration of large doses. A regular check of patency should be maintained (see section 4.4).</p><p><u>Treatment of intoxication</u></p><p>Gastrointestinal symptoms may be treated symptomatically, with attention to the water/electrolyte balance.</p><p>Amoxicillin/clavulanic acid can be removed from the circulation by haemodialysis.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>Pharmacotherapeutic group: Combinations of penicillins, incl. beta-lactamase inhibitors; ATC code: J01CR02.</p><p><u>Mechanism of action</u></p><p>Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bacterial peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death.</p><p>Amoxicillin is susceptible to degradation by beta-lactamases produced by resistant bacteria and therefore the spectrum of activity of amoxicillin alone does not include organisms which produce these enzymes.</p><p>Clavulanic acid is a beta-lactam structurally related to penicillins. It inactivates some beta-lactamase enzymes thereby preventing inactivation of amoxicillin. Clavulanic acid alone does not exert a clinically useful antibacterial effect.</p><p><u>Pharmacokinetic/pharmacodynamic relationship</u></p><p>The time above the minimum inhibitory concentration (T&gt;MIC) is considered to be the major determinant of efficacy for amoxicillin.</p><p><u>Mechanisms of resistance</u></p><p>The two main mechanisms of resistance to amoxicillin/clavulanic acid are:</p><p>&bull; Inactivation by those bacterial beta-lactamases that are not themselves inhibited by clavulanic acid, including class B, C and D.</p><p>&bull; Alteration of PBPs, which reduce the affinity of the antibacterial agent for the target.</p><p>Impermeability of bacteria or efflux pump mechanisms may cause or contribute to bacterial resistance, particularly in Gram-negative bacteria.</p><p><u>Breakpoints</u></p><p>MIC breakpoints for amoxicillin/clavulanic acid are those of the European Committee on Antimicrobial Susceptibility Testing (EUCAST).</p><table border="1" cellspacing="0" cellpadding="0" style="width:691px"><tbody><tr><td style="vertical-align:top"><p>Organism</p></td><td colspan="3" style="vertical-align:top"><p>Susceptibility Breakpoints (&mu;g/ml)</p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Susceptible</p></td><td style="vertical-align:top"><p>Intermediate</p></td><td style="vertical-align:top"><p>Resistant</p></td></tr><tr><td style="vertical-align:top"><p><em>Haemophilus influenzae</em><strong><sup>1</sup></strong></p></td><td style="vertical-align:top"><p>&le; 1</p></td><td style="vertical-align:top"><p>-</p></td><td style="vertical-align:top"><p>&gt; 1</p></td></tr><tr><td style="vertical-align:top"><p><em>Moraxella catarrhalis</em><strong><sup>1</sup></strong></p></td><td style="vertical-align:top"><p>&le; 1</p></td><td style="vertical-align:top"><p>-</p></td><td style="vertical-align:top"><p>&gt; 1</p></td></tr><tr><td style="vertical-align:top"><p><em>Staphylococcus aureus&nbsp;</em><strong><sup>2</sup></strong></p></td><td style="vertical-align:top"><p>&le; 2</p></td><td style="vertical-align:top"><p>-</p></td><td style="vertical-align:top"><p>&gt; 2</p></td></tr><tr><td style="vertical-align:top"><p>Coagulase-negative staphylococci&nbsp;<strong><sup>2</sup></strong></p></td><td style="vertical-align:top"><p>&le; 0.25</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>&gt; 0.25</p></td></tr><tr><td style="vertical-align:top"><p><em>Enterococcus</em><strong><sup>1</sup></strong></p></td><td style="vertical-align:top"><p>&le; 4</p></td><td style="vertical-align:top"><p>8</p></td><td style="vertical-align:top"><p>&gt; 8</p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus A, B, C, G</em><strong><sup>5</sup></strong></p></td><td style="vertical-align:top"><p>&le; 0.25</p></td><td style="vertical-align:top"><p>-</p></td><td style="vertical-align:top"><p>&gt; 0.25</p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus pneumoniae</em><strong><sup>3</sup></strong></p></td><td style="vertical-align:top"><p>&le; 0.5</p></td><td style="vertical-align:top"><p>1-2</p></td><td style="vertical-align:top"><p>&gt; 2</p></td></tr><tr><td style="vertical-align:top"><p>Enterobacteriaceae<strong><sup>1,4</sup></strong></p></td><td style="vertical-align:top"><p>-</p></td><td style="vertical-align:top"><p>-</p></td><td style="vertical-align:top"><p>&gt; 8</p></td></tr><tr><td style="vertical-align:top"><p>Gram-negative Anaerobes<strong><sup>1</sup></strong></p></td><td style="vertical-align:top"><p>&le; 4</p></td><td style="vertical-align:top"><p>8</p></td><td style="vertical-align:top"><p>&gt; 8</p></td></tr><tr><td style="vertical-align:top"><p>Gram-positive Anaerobes<strong><sup>1</sup></strong></p></td><td style="vertical-align:top"><p>&le; 4</p></td><td style="vertical-align:top"><p>8</p></td><td style="vertical-align:top"><p>&gt; 8</p></td></tr><tr><td style="vertical-align:top"><p>Non-species related breakpoints<strong><sup>1</sup></strong></p></td><td style="vertical-align:top"><p>&le; 2</p></td><td style="vertical-align:top"><p>4-8</p></td><td style="vertical-align:top"><p>&gt; 8</p></td></tr><tr><td colspan="4" style="vertical-align:top"><p><sup>1</sup>&nbsp;The reported values are for amoxicillin concentrations. For susceptibility testing purposes, the concentration of clavulanic acid is fixed at 2 mg/l.</p><p><sup>2</sup>&nbsp;The reported values are oxacillin concentrations.</p><p><sup>3</sup>&nbsp;Breakpoint values in the table are based on ampicillin breakpoints.</p><p><sup>4</sup>&nbsp;The resistant breakpoint of R&gt;8 mg/l ensures that all isolates with resistance mechanisms are reported resistant.</p><p><sup>5</sup>&nbsp;Breakpoint values in the table are based on benzylpenicillin breakpoints.</p></td></tr></tbody></table><p>The prevalence of resistance may vary geographically and with time for selected species, and local information on resistance is desirable, particularly when treating severe infections. As necessary, expert advice should be sought when the local prevalence of resistance is such that the utility of the agent in at least some types of infections is questionable.</p><table border="1" cellspacing="0" cellpadding="0" style="width:691px"><tbody><tr><td style="vertical-align:top"><p><u>Commonly susceptible species</u></p></td></tr><tr><td style="vertical-align:top"><p><u>Aerobic Gram-positive micro-organisms</u></p><p><em>Enterococcus faecalis</em></p><p><em>Gardnerella vaginalis</em></p><p><em>Staphylococcus aureus&nbsp;</em>(methicillin-susceptible)&pound;</p><p>Coagulase-negative staphylococci (methicillin-susceptible)</p><p><em>Streptococcus agalactiae</em></p><p><em>Streptococcus pneumoniae</em><sup>1</sup></p><p><em>Streptococcus pyogenes</em>&nbsp;and other beta-haemolytic streptococci</p><p><em>Streptococcus viridans&nbsp;</em>group</p><p><u>Aerobic Gram-negative micro-organisms</u></p><p><em>Capnocytophaga&nbsp;</em>spp.</p><p><em>Eikenella corrodens</em></p><p><em>Haemophilus influenzae</em><sup>2</sup></p><p><em>Moraxella catarrhalis</em></p><p><em>Pasteurella multocida</em></p><p><u>Anaerobic micro-organisms</u></p><p><em>Bacteroides fragilis</em></p><p><em>Fusobacterium nucleatum</em></p><p><em>Prevotella</em>&nbsp;spp.</p></td></tr><tr><td style="vertical-align:top"><p><u>Species for which acquired resistance may be a problem</u></p></td></tr><tr><td style="vertical-align:top"><p><u>Aerobic Gram-positive micro-organisms</u></p><p><em>Enterococcus faecium&nbsp;</em>$</p><p><u>Aerobic Gram-negative micro-organisms</u></p><p><em>Escherichia coli</em></p><p><em>Klebsiella oxytoca</em></p><p><em>Klebsiella pneumoniae</em></p><p><em>Proteus mirabilis</em></p><p><em>Proteus vulgaris</em></p></td></tr><tr><td style="vertical-align:top"><p><u>Inherently resistant organisms</u></p></td></tr><tr><td style="vertical-align:top"><p><u>Aerobic Gram-negative micro-organisms</u></p><p><em>Acinetobacter&nbsp;</em>sp.</p><p><em>Citrobacter freundii</em></p><p><em>Enterobacter</em>&nbsp;sp.</p><p><em>Legionella pneumophila</em></p><p><em>Morganella morganii</em></p><p><em>Providencia&nbsp;</em>spp.</p><p><em>Pseudomonas&nbsp;</em>sp.</p><p><em>Serratia&nbsp;</em>sp.</p><p><em>Stenotrophomonas maltophilia</em></p><p><u>Other micro-organisms</u></p><p><em>Chlamydophila pneumoniae</em></p><p><em>Chlamydophila psittaci</em></p><p><em>Coxiella burnetti</em></p><p><em>Mycoplasma pneumoniae</em></p></td></tr><tr><td style="vertical-align:top"><p>$ Natural intermediate susceptibility in the absence of acquired mechanism of resistance.</p><p>&pound; All methicillin-resistant staphylococci are resistant to amoxicillin/clavulanic acid</p><p><sup>1</sup><em>Streptococcus pneumoniae</em>&nbsp;that are resistant to penicillin should not be treated with this presentation of amoxicillin/clavulanic acid (see sections 4.2 and 4.4).</p><p><sup>2&nbsp;</sup>Strains with decreased susceptibility have been reported in some countries in the EU with a frequency higher than 10%.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u></p><p>Amoxicillin and clavulanic acid, are fully dissociated in aqueous solution at physiological pH. Both components are rapidly and well absorbed by the oral route of administration. Following oral administration, amoxicillin and clavulanic acid are approximately 70% bioavailable. The plasma profiles of both components are similar and the time to peak plasma concentration (T<sub>max</sub>) in each case is approximately one hour.</p><p>The pharmacokinetic results for a study, in which amoxicillin/clavulanic acid (500 mg/125 mg tablets three times daily) was administered in the fasting state to groups of healthy volunteers are presented below.</p><table border="1" cellspacing="0" cellpadding="0" style="width:691px"><tbody><tr><td colspan="6" style="vertical-align:top"><p>Mean (&plusmn; SD) pharmacokinetic parameters</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Active substance(s) administered</p></td><td style="vertical-align:top"><p>Dose</p></td><td style="vertical-align:top"><p>C<sub>max</sub></p></td><td style="vertical-align:top"><p>T<sub>max&nbsp;</sub>*</p></td><td style="vertical-align:top"><p>AUC&nbsp;<sub>(0-24h)</sub></p></td><td style="vertical-align:top"><p>T 1/2</p></td></tr><tr><td style="vertical-align:top"><p>(mg)</p></td><td style="vertical-align:top"><p>(&mu;g/ml)</p></td><td style="vertical-align:top"><p>(h)</p></td><td style="vertical-align:top"><p>(&mu;g.h/ml)</p></td><td style="vertical-align:top"><p>(h)</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p>Amoxicillin</p></td></tr><tr><td style="vertical-align:top"><p>AMX/CA</p><p>500/125 mg</p></td><td style="vertical-align:top"><p>500</p></td><td style="vertical-align:top"><p>7.19</p><p>&plusmn; 2.26</p></td><td style="vertical-align:top"><p>1.5</p><p>(1.0-2.5)</p></td><td style="vertical-align:top"><p>53.5</p><p>&plusmn; 8.87</p></td><td style="vertical-align:top"><p>1.15</p><p>&plusmn; 0.20</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p>Clavulanic acid</p></td></tr><tr><td style="vertical-align:top"><p>AMX/CA</p><p>500 mg/125 mg</p></td><td style="vertical-align:top"><p>125</p></td><td style="vertical-align:top"><p>2.40</p><p>&plusmn; 0.83</p></td><td style="vertical-align:top"><p>1.5</p><p>(1.0-2.0)</p></td><td style="vertical-align:top"><p>15.72</p><p>&plusmn; 3.86</p></td><td style="vertical-align:top"><p>0.98</p><p>&plusmn; 0.12</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p>AMX &ndash; amoxicillin, CA &ndash; clavulanic acid</p><p>* Median (range)</p></td></tr></tbody></table><p>Amoxicillin and clavulanic acid serum concentrations achieved with amoxicillin/clavulanic acid are similar to those produced by the oral administration of equivalent doses of amoxicillin or clavulanic acid alone.</p><p><u>Distribution</u></p><p>About 25% of total plasma clavulanic acid and 18% of total plasma amoxicillin is bound to protein. The apparent volume of distribution is around 0.3-0.4 l/kg for amoxicillin and around 0.2 l/kg for clavulanic acid.</p><p>Following intravenous administration, both amoxicillin and clavulanic acid have been found in gall bladder, abdominal tissue, skin, fat, muscle tissues, synovial and peritoneal fluids, bile and pus. Amoxicillin does not adequately distribute into the cerebrospinal fluid.</p><p>From animal studies there is no evidence for significant tissue retention of drug-derived material for either component. Amoxicillin, like most penicillins, can be detected in breast milk. Trace quantities of clavulanic acid can also be detected in breast milk (see section 4.6).</p><p>Both amoxicillin and clavulanic acid have been shown to cross the placental barrier (see section 4.6).</p><p><u>Biotransformation</u></p><p>Amoxicillin is partly excreted in the urine as the inactive penicilloic acid in quantities equivalent to up to 10 to 25% of the initial dose. Clavulanic acid is extensively metabolized in man and eliminated in urine and faeces, and as carbon dioxide in expired air.</p><p><u>Elimination</u></p><p>The major route of elimination for amoxicillin is via the kidney, whereas for clavulanic acid it is by both renal and non-renal mechanisms.</p><p>Amoxicillin/clavulanic acid has a mean elimination half-life of approximately one hour and a mean total clearance of approximately 25 l/h in healthy subjects. Approximately 60 to 70% of the amoxicillin and approximately 40 to 65% of the clavulanic acid are excreted unchanged in urine during the first 6 h after administration of single Gloclav 250 mg/125 mg or 500 mg/125 mg tablets. Various studies have found the urinary excretion to be 50-85% for amoxicillin and between 27-60% for clavulanic acid over a 24 hour period. In the case of clavulanic acid, the largest amount of drug is excreted during the first 2 hours after administration.</p><p>Concomitant use of probenecid delays amoxicillin excretion but does not delay renal excretion of clavulanic acid (see section 4.5).</p><p><u>Age</u></p><p>The elimination half-life of amoxicillin is similar for children aged around 3 months to 2 years and older children and adults. For very young children (including preterm newborns) in the first week of life the interval of administration should not exceed twice daily administration due to immaturity of the renal pathway of elimination. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.</p><p><u>Gender</u></p><p>Following oral administration of amoxicillin/clavulanic acid to healthy males and female subjects, gender has no significant impact on the pharmacokinetics of either amoxicillin or clavulanic acid.</p><p><u>Renal impairment</u></p><p>The total serum clearance of amoxicillin/clavulanic acid decreases proportionately with decreasing renal function. The reduction in drug clearance is more pronounced for amoxicillin than for clavulanic acid, as a higher proportion of amoxicillin is excreted&nbsp;<em>via&nbsp;</em>the renal route. Doses in renal impairment must therefore prevent undue accumulation of amoxicillin while maintaining adequate levels of clavulanic acid (see section 4.2).</p><p><u>Hepatic impairment</u></p><p>Hepatically impaired patients should be dosed with caution and hepatic function monitored at regular intervals.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data reveal no special hazard for humans based on studies of safety pharmacology, genotoxicity and toxicity to reproduction.</p><p>Repeat dose toxicity studies performed in dogs with amoxicillin/clavulanic acid demonstrate gastric irritancy and vomiting, and discoloured tongue.</p><p>Carcinogenicity studies have not been conducted with amoxicillin/clavulanic acid.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tablet excipients:</p><p>Magnesium Stearate,</p><p>Sodium Starch Glycollate,</p><p>Colloidal Anhydrous Silica,</p><p>Microcrystalline Cellulose.</p><p>&nbsp;</p><p>Coating excipients:</p><p>Hypermellose E15,</p><p>Ethyl Cellulose,</p><p>Propylene Glycol,</p><p>Isopropyl Alcohol*,</p><p>Opaspray K-1R-7000 White,</p><p>Dimeticone,</p><p>Methylene Chloride*.</p><p>* Not present in the final formulation, evaporates upon drying</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 Months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C. Store in a dry place. Protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Gloclav 625mg film-coated tablets are packaged in blister packs of 20 tablets (10&rsquo;s Blister X 2).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Globalpharma Co. L.L.C. Dubai Investment Park, Jebel Ali, Dubai, United Arab Emirates
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                31th March 2019 
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>